Nasus Pharma Ltd (NSRX) Institutional Ownership Changes & 13F Activity
Nasus Pharma Ltd (NSRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Empery Asset Management, Lp, Hrt Financial Lp, Citadel Advisors Llc, Xtx Topco Ltd, and Cable Car Capital, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +22,004 | — | 22,004 | $77.01K | Q2 2026 | Sep 02, 2026 |
| Xtx Topco Ltd | Buy | +16,640 | — | 16,640 | $58.24K | Q2 2026 | Aug 14, 2026 |
| Cable Car Capital, Lp | Buy | +14,083 | +2.3% | 616,081 | $2.16M | Q2 2026 | Aug 14, 2026 |
| Renaissance Technologies LLC | Buy | +12,200 | — | 12,200 | $42.70K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Sell | -1,000 | -50.0% | 1,000 | $3.50K | Q2 2026 | Aug 13, 2026 |
| Caitong International Asset Management Co., Ltd | Buy | +4 | — | 4 | $14.00 | Q2 2026 | Aug 05, 2026 |
| Hrt Financial Lp | Sell | -38,897 | -100.0% | 0 | $0.00 | Q2 2026 | May 14, 2026 |
| Empery Asset Management, Lp | Sell | -45,803 | -100.0% | 0 | $0.00 | Q2 2026 | May 08, 2026 |
| Ubs Group Ag | Sell | -3,094 | -100.0% | 0 | $0.00 | Q2 2026 | May 05, 2026 |
Frequently asked questions about NSRX activity
Which institutional owners are buying NSRX?
Institutional owners buying NSRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in NSRX activity?
"Buy" means an investor increased their reported position in NSRX compared to the prior reporting period. This reflects growing exposure to Nasus Pharma Ltd (NSRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in NSRX increasing?
Institutional interest in NSRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.